These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23297040)

  • 1. Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination.
    Brisson M; Drolet M; Malagón T
    J Natl Cancer Inst; 2013 Feb; 105(3):158-61. PubMed ID: 23297040
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels and Re: Inequalities in human papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination.
    Harper DM; Groner JA; Griffith RS; Harper WH
    J Natl Cancer Inst; 2013 May; 105(10):749-50. PubMed ID: 23641042
    [No Abstract]   [Full Text] [Related]  

  • 3. Response.
    Boily MC; Brisson M; Drolet M; Malagón T
    J Natl Cancer Inst; 2013 May; 105(10):750-1. PubMed ID: 23814885
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diseases caused by human papillomavirus -- the possibilities and the public health advantages of prevention].
    Acs N; Bata Z; Danko D; Hernádi Z; Kálmán M; Kornya L; Kovács J; Mézáros G; Molnár MP; Mór Z; Novák Z; Sobel G; Szentirmay Z; Takács L; Tisza T
    Orv Hetil; 2012 Dec; 153 Suppl():3-38. PubMed ID: 23687666
    [No Abstract]   [Full Text] [Related]  

  • 5. [To the Editors: HPV vaccination].
    Katona G
    Orv Hetil; 2013 Jul; 154(30):1197. PubMed ID: 23876618
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of papillomavirus-associated cancer].
    Signorelli C
    Ann Ig; 2008; 20(3 Suppl 1):65-74. PubMed ID: 18773608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of cancers with human papillomavirus vaccination.
    CA Cancer J Clin; 2016 Sep; 66(5):386. PubMed ID: 27434855
    [No Abstract]   [Full Text] [Related]  

  • 9. Human papillomavirus infection and related cancers in sub-Saharan Africa: burden and tools for prevention.
    Awolude OA; Morhason-Bello IO; Denny LA; Adewole IF
    Vaccine; 2013 Dec; 31 Suppl 5():vii-x. PubMed ID: 24331751
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
    Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccine: widening the scope for cancer prevention.
    No JH; Kim MK; Jeon YT; Kim YB; Song YS
    Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real world effectiveness of population-based roll out of human papillomavirus vaccination against rates of genital warts.
    Smith JS; Weiderpass E
    J Natl Cancer Inst; 2013 Apr; 105(7):449-51. PubMed ID: 23486549
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: HPV vaccination: preventing more cancers in future generations.
    Kelly D
    J Clin Nurs; 2014 Apr; 23(7-8):909-10. PubMed ID: 24606392
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytology and DNA HPV-testing in the era of HPV-vaccine].
    Spaczyński M; Malkowska-Walczak B; Nowak-Markwitz E
    Ginekol Pol; 2007 Sep; 78(9):696-700. PubMed ID: 18159823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
    Watson M; Saraiya M; Ahmed F; Cardinez CJ; Reichman ME; Weir HK; Richards TB
    Cancer; 2008 Nov; 113(10 Suppl):2841-54. PubMed ID: 18980203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beginning of the end: vaccine prevention of HPV-driven cancers.
    Giuliano AR; Kreimer AR; de Sanjose S
    J Natl Cancer Inst; 2015 Apr; 107(6):djv128. PubMed ID: 25911509
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus infection among young adolescents in India: impact of vaccination.
    Hussain S; Bharadwaj M; Nasare V; Kumari M; Sharma S; Hedau S; Das BC
    J Med Virol; 2012 Feb; 84(2):298-305. PubMed ID: 22170551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postlicensure monitoring of HPV vaccination programmes.
    Markowitz LE; Hariri S
    Lancet Infect Dis; 2014 Oct; 14(10):904-5. PubMed ID: 25107681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.